Ground Swell Capital’s Quoin Pharmaceuticals QNRX Stock Holding History

Ground Swell Capital’s Portfolio QNRX Stock Details QNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-87	Closed	-$82K	–	132
2022 Q3	$82K	Buy	+87	New	+$179K	0.23%	68

Other funds holding QNRX

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Ground Swell Capital's QNRX Position: Q4 2022 in Review

Ground Swell Capital sold out of Quoin Pharmaceuticals (QNRX) in Q4 2022, closing a stake of 87 shares — an estimated $82K sold.

Ground Swell Capital first reported a position in QNRX in Q3 2022 and held it in 1 quarter. The position peaked at $82K in Q3 2022. 3 funds tracked by Wall St. Rank hold QNRX as of Q4 2022.

Ground Swell Capital reported no remaining Quoin Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Ground Swell Capital sold 87 Quoin Pharmaceuticals shares in Q4 2022, an estimated $82K.
Ground Swell Capital first reported a position in Quoin Pharmaceuticals in Q3 2022 and held it in 1 quarter.
Ground Swell Capital's Quoin Pharmaceuticals position peaked at $82K in Q3 2022.
3 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q4 2022.

Based on Ground Swell Capital's 13F filing for Q4 2022, filed 14 Feb 2023.